Charles Schwab Investment Management Inc. reduced its holdings in Envista Holdings Co. (NYSE:NVST – Free Report) by 12.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,138,031 shares of the company’s stock after selling 306,382 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.24% of Envista worth $42,247,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of NVST. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Envista in the 3rd quarter valued at approximately $31,000. GAMMA Investing LLC boosted its stake in shares of Envista by 69.8% in the 3rd quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock valued at $35,000 after purchasing an additional 726 shares during the last quarter. Huntington National Bank lifted its stake in shares of Envista by 97.8% in the 3rd quarter. Huntington National Bank now owns 1,919 shares of the company’s stock valued at $38,000 after purchasing an additional 949 shares during the period. Blue Trust Inc. increased its stake in shares of Envista by 69.7% in the 3rd quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock valued at $39,000 after acquiring an additional 804 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC increased its stake in Envista by 50.8% in the third quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after purchasing an additional 728 shares in the last quarter.
Envista Stock Down 0.2 %
NYSE NVST opened at $22.29 on Monday. The company has a market cap of $3.84 billion, a price-to-earnings ratio of -2.87, a PEG ratio of 3.10 and a beta of 1.30. Envista Holdings Co. has a 1-year low of $15.15 and a 1-year high of $25.64. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. The company has a 50 day moving average of $19.79 and a 200-day moving average of $18.28.
Analyst Ratings Changes
NVST has been the subject of several research analyst reports. JPMorgan Chase & Co. cut shares of Envista from an “overweight” rating to a “neutral” rating and reduced their price target for the company from $23.00 to $16.00 in a report on Thursday, August 8th. Robert W. Baird increased their price objective on shares of Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a research note on Thursday, October 31st. Leerink Partners raised Envista from an “underperform” rating to a “market perform” rating and lifted their target price for the company from $16.00 to $23.00 in a research report on Thursday, October 31st. Needham & Company LLC reissued a “hold” rating on shares of Envista in a research note on Thursday, October 31st. Finally, Piper Sandler upped their price target on shares of Envista from $16.00 to $17.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, Envista has an average rating of “Hold” and an average price target of $20.71.
View Our Latest Research Report on NVST
Envista Company Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Read More
- Five stocks we like better than Envista
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- Consumer Discretionary Stocks Explained
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- How to Choose Top Rated Stocks
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.